Table 2.
Overview of all IBD patients with COVID-19 who died.
| Case number | Age | Gender | Comorbidity | IBD type | IBD duration | Disease activity | IBD medication | Symptoms | GI symptoms | COVID-19 treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 80 | Male | CVD | UC | 45 y | Remission | No | Fever | No | No | Hospital admission, died after 10 days |
| COPD | Headache | ||||||||||
| Lymphoma | Cough | ||||||||||
| Sore throat | |||||||||||
| Fatigue | |||||||||||
| 2 | 86 | Male | Diabetes | CD | 12 y | Remission | Aminosalicylates | Unknown | Unknown | Unknown | No hospital admission, died at home |
| Hypertension | Azathioprine | ||||||||||
| CVD | |||||||||||
| CVA | |||||||||||
| NASH | |||||||||||
| 3 | 76 | Female | Diabetes | UC | 1 m | Unknown | Aminosalicylates | Fever with chills | Diarrhoea | Hydroxy-chloroquine | Hospital admission, died after 11 days |
| Hypertension | Prednisolone | Headache | Antibiotics | ||||||||
| CVD | 6-mercaptopurine | Cough | |||||||||
| CVA | Sore throat | ||||||||||
| Vascular renal disease | Fatigue | ||||||||||
| Shortness of breath | |||||||||||
| 4 | 83 | Female | Hypertension | UC | 22 y | Remission | Aminosalicylates | Fever | Nausea | Hydroxy-chloroquine | Hospital admission, died after 16 days |
| CVD | Cough | Antibiotics | |||||||||
| Sputum production | |||||||||||
| Sore throat | |||||||||||
| Fatigue | |||||||||||
| Shortness of breath | |||||||||||
| 5 | 69 | Female | Hypertension | CD | 2 m | Remission | Prednisolone | Fever | Diarrhoea | Lopinavir | Hospital admission, died after 9 days |
| Azathioprine | Fatigue | Antibiotics | |||||||||
| Shortness of breath | |||||||||||
| 6 | 72 | Male | Diabetes | UC | 10 y | Mild | Aminosalicylates | Unknown | Diarrhoea | Antibiotics | Admission to intensive care unit, mechanical ventilation, died after 1 day |
| Hypertension | Prednisolone | ||||||||||
| CVD | Azathioprine | ||||||||||
| 7 | 77 | Male | CVD | UC | 9 y | Remission | Aminosalicylates | Fever | Diarrhoea | Chloroquine | Hospital admission, died after 5 days |
| Azathioprine | Cough | Antibiotics | |||||||||
| Sputum production | |||||||||||
| Fatigue | |||||||||||
| Shortness of breath | |||||||||||
| 8 | 64 | Female | Cancer | UC | 3 y | Moderate | Prednisolone | Fever | Diarrhoea | No | Hospital admission, died |
| Fatigue | |||||||||||
| Shortness of breath | |||||||||||
| 9 | 68 | Male | Diabetes | UC | 6 y | Remission | No | Cough | Diarrhoea | Chloroquine | Admission to intensive care unit, mechanical ventilation, died after 1 day |
| Hypertension | Sputum production | Antibiotics | |||||||||
| CVD | Fatigue | ||||||||||
| Asthma | Shortness of breath | ||||||||||
| 10 | 75 | Male | Diabetes | UC | 2 y | Remission | No | Chills | Chloroquine | Admission to intensive care unit, mechanical ventilation, died after 3 days | |
| CVD | Cough | ||||||||||
| Asthma | Shortness of breath | ||||||||||
| Prostate carcinoma | |||||||||||
| Renal insufficiency resulting in kidney transplant | |||||||||||
| 11 | 78 | Female | CVD | UC | 16 y | Remission | Aminosalicylates | Cough | Diarrhoea | No | Hospital admission, died after 3 days |
| Asthma/COPD | Sputum production | ||||||||||
| Mammary carcinoma | Shortness of breath | ||||||||||
| 12 | 86 | Female | Hypertension | UC | 56 y | Remission | Aminosalicylates | Cough | No | Unknown | Hospital admission, died after 14 days |
| CVD | Fatigue | ||||||||||
| CVA | Shortness of breath | ||||||||||
| 13 | 85 | Male | Prostate carcinoma | UC | 51 y | Remission | Budesonide | Fever | No | No | Hospital admission, died after 18 days |
| Chronic liver disease | Fatigue |
CVD, cardiovascular disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; NASH, non-alcoholic steatosis hepatis; GI, gastrointestinal; y, year; m, month; BMI, body mass index; IBD, inflammatory bowel disease; IQR, interquartile range; TNF, tumour necrosis factor; UC, ulcerative colitis; CD, Crohn’s disease.